Illustration of a clinic building (not a photo of Cincinnati Pet Scan)
Illustration

Matthew H. Bertke, MD

Radiation Oncology in Cincinnati, OH

  • Enrolled in Medicare
  • Accepts Medicare assignment
  • 14 years since graduation
  • Public record — not managed by the clinician

About Dr. Matthew Bertke

Dr. Matthew Bertke is a physician specializing in radiation oncology practicing in Cincinnati, OH, a graduate of University of Louisville School of Medicine (2012). Records list 2 practice addresses. Affiliated with Bethesda North, Christ Hospital, Good Samaritan Hospital and 2 more. Treated 387 Medicare patients in 2024.

Provider details

SpecialtyRadiation OncologyOther radiation oncology doctors in Cincinnati
CredentialsMD
EducationUniversity of Louisville School of Medicine, 2012CMS Doctors and Clinicians
GenderMale
NPI number1083971683National Provider Identifier (CMS NPPES), issued April 2012
MedicareEnrolled in Medicare; accepts Medicare assignment (the Medicare-approved amount as full payment)CMS Doctors and Clinicians

Dr. Matthew Bertke's specialties and state licenses

  • Radiation Oncology Primary
    License: OH 35.140910
  • Radiation Oncology
    License: GA 77947
  • Radiation Oncology
    License: KY R2872

As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.

Where Dr. Matthew Bertke practices

Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.

Hospital affiliations of Dr. Matthew Bertke

  • Bethesda NorthHospital · Cincinnati, OH
  • Christ HospitalHospital · Cincinnati, OH
  • Good Samaritan HospitalHospital · Cincinnati, OH
  • Mercy Health - West HospitalHospital · Cincinnati, OH
  • St Elizabeth Medical Center NorthHospital · Edgewood, KY

CMS Facility Affiliation data: facilities where the clinician bills Medicare.

Dr. Matthew Bertke's Medicare patients and services (2024)

387Medicare patients
4,491services billed
74average patient age
20%women

Most frequent services

ServiceTimesAvg. Medicare allowed
Ct guidance for insertion of radiation therapy fields461$109.56
Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session432$318.17
Calculation of radiation therapy dose426$60.97
Continuing radiation therapy consultation per week194$79.82
Image-guided robotic linear accelerator-based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, second through fifth sessions, maximum five sessions per course of treatme181$2,398.35
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more167$85.66
Radiation treatment management, 5 treatment sessions145$180.64
Design and construction of complex radiation treatment device104$115.84

Common conditions among these patients

  • Cancer75%
  • High cholesterol75%
  • High blood pressure75%
  • Arthritis40%
  • Ischemic heart disease33%
  • Diabetes28%

Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.

Payments from drug and device companies to Dr. Matthew Bertke (2025)

$690.25 in 26 general payments reported in 2025.

TypePaymentsAmount
Food and beverage25$669.25
Education1$21

Paying companies: NOVARTIS PHARMACEUTICALS CORPORATION ($150.56), Janssen Scientific Affairs, LLC ($124.22), ImmunityBio, Inc. ($67.05), Janssen Biotech, Inc. ($52.70), Dendreon Pharmaceuticals LLC ($49.05), Bayer HealthCare Pharmaceuticals Inc. ($44.72).

Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.

Also at Cincinnati Pet Scan

Questions about Dr. Matthew Bertke

What kind of clinician is Dr. Matthew Bertke?

Dr. Matthew Bertke is listed as a physician specializing in radiation oncology.

Where does Dr. Matthew Bertke practice?

Cincinnati Pet Scan at 3301 Mercy Health Blvd, Suite 100, Cincinnati, OH 45211, and 1 other address in the records.

What is the office phone number for Dr. Matthew Bertke?

The listed office number is (513) 751-2273. Call to confirm availability and whether new patients are accepted.

What is the NPI number of Dr. Matthew Bertke?

The National Provider Identifier is 1083971683.

Does Dr. Matthew Bertke accept Medicare?

Yes. CMS lists this clinician as accepting Medicare assignment. Confirm your plan with the office.

Which hospitals is Dr. Matthew Bertke affiliated with?

Bethesda North, Christ Hospital, Good Samaritan Hospital, Mercy Health - West Hospital, St Elizabeth Medical Center North.

Where did Dr. Matthew Bertke go to medical school?

University of Louisville School of Medicine, graduating in 2012.

Where this information comes from

CMS Doctors and CliniciansName, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026)
NPPES NPI registryNPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2023-02-14
Facility affiliationsHospitals and other facilities.CMS Doctors and Clinicians facility affiliation file; names from CMS Provider of Services
Medicare utilizationPatients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024
Open PaymentsPayments from drug and device companies.CMS Open Payments, program year 2025

Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.

Need an appointment?

Call Cincinnati Pet Scan at (513) 751-2273 or visit the clinic page to check availability.

Call now
0 clinics selected Compare